PRKAA1 and hepatocellular carcinoma: Further experiments with the AMPK activators metformin or 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) in rat hepatoma cells and hepatocytes activate AMPK, thereby inhibiting the blocking function of ethanol on ACC and SREBP-1c [143].